Annals of oncology : official journal of the European Society for Medical Oncology

Estrogens and breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology

Kim J, Munster PN

Maintenance lenalidomide in primary CNS lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology

Rubenstein JL, Geng H, Vu K, Mannis G, Formaker P, Hwang J, Munster PN, Damato B

A phase I dose-escalation and dose-expansion study of brontictuzumab in subjects with selected solid tumors.

Annals of oncology : official journal of the European Society for Medical Oncology

Ferrarotto R, Eckhardt G, Patnaik A, LoRusso P, Faoro L, Heymach JV, Kapoun AM, Xu L, Munster P

Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canal.

Annals of oncology : official journal of the European Society for Medical Oncology

Ott PA, Piha-Paul SA, Munster P, Pishvaian MJ, van Brummelen EMJ, Cohen RB, Gomez-Roca C, Ejadi S, Stein M, Chan E, Simonelli M, Morosky A, Saraf S, Emancipator K, Koshiji M, Bennouna J

A phase I trial of panobinostat and epirubicin in solid tumors with a dose expansion in patients with sarcoma.

Annals of oncology : official journal of the European Society for Medical Oncology

Thomas S, Aggarwal R, Jahan T, Ryan C, Troung T, Cripps AM, Raha P, Thurn KT, Chen S, Grabowsky JA, Park J, Hwang J, Daud A, Munster PN

Can ovarian suppression with gonadotropin-releasing hormone analogs (GnRHa) preserve fertility in cancer patients?

Annals of oncology : official journal of the European Society for Medical Oncology

Rodriguez-Wallberg K, Turan V, Munster P, Oktay K

Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates.

Annals of oncology : official journal of the European Society for Medical Oncology

Kelley RK, Nimeiri HS, Munster PN, Vergo MT, Huang Y, Li CM, Hwang J, Mulcahy MF, Yeh BM, Kuhn P, Luttgen MS, Grabowsky JA, Stucky-Marshall L, Korn WM, Ko AH, Bergsland EK, Benson AB, Venook AP

Phase II study of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, in patients with locally advanced or metastatic breast cancer pretreated with chemotherapy.

Annals of oncology : official journal of the European Society for Medical Oncology

Campone M, Bondarenko I, Brincat S, Hotko Y, Munster PN, Chmielowska E, Fumoleau P, Ward R, Bardy-Bouxin N, Leip E, Turnbull K, Zacharchuk C, Epstein RJ